PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ — Aphex BioCleanse Systems, Inc. (OTCPK: SNST) (“Aphex” or “the Company”) , a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products trademarked as Hy-IQ® Water, announced today that the Company has signed a supply and private label agreement with Qurexx B.V. (“Qurexx”).
As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex’s DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals.
“Our chemical-free, water-based products offer a safer and more environmentally-friendly option to the quickly-expanding European sanitization market. Qurexx B.V. has a strong understanding of the European sanitization landscape and will serve as a key partner as we aim to expand access to and education on our products across Europe ,” said Aphex President and CEO David J. Weaver .
The Company has identified Europe as a key market for expansion as the continent’s sanitization market has seen a large increase due to the COVID-19 pandemic. As a result, Europe’s hand sanitizer market alone is expected to reach $2.1 billion by 2026. Through this agreement, Aphex will leverage Qurexx’s key partnerships and distribution channels to increase accessibility of the Company’s water-based sanitization products across Europe.
As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.
“We chose to partner with Aphex because we believe their products offer a clean sanitization option that European consumers have been waiting for and will respond positively to. As we work to bring the company’s products to stores across Europe , we look forward to a strong and long-lasting partnership with Aphex,” said Dr. Frank Hoefer , Managing Director for Qurexx B.V.
About Aphex BioCleanse Systems, Inc.
Aphex BioCleanse Systems, Inc is the developer of the world’s first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ® Water, has a unique method of action that uses hydrogen ions traveling nearly at the speed of light to breach the cell walls of exoskeleton germs. Preliminary research has proven that it is more effective in killing pathogens than alcohol-based solutions and the company is currently seeking to be the first FDA-approved hand sanitizer. Learn more about Aphex at www.aphexus.com .
FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
[email protected]
www.aphexus.com
Phone: 1-585-386-0990
Address:
Aphex BioCleanse Systems Inc.
15 Fishers Rd, #111
Pittsford, NY 14534
For media inquiries, please contact:
Kathryn Brown
[email protected]
858-264-6600
